ESMO 2026 - postMONARCH: The Survival Update with Dr. Kevin Kalinsky

The postMONARCH story continues. Dr. Kevin Kalinsky puts the final overall survival analysis into perspective, alongside updated efficacy and safety data, in advanced breast cancer after progression on a CDK4/6 inhibitor.